Format

Send to

Choose Destination
See comment in PubMed Commons below
Naunyn Schmiedebergs Arch Pharmacol. 2009 Apr;379(4):409-12. doi: 10.1007/s00210-008-0368-6. Epub 2008 Nov 7.

Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific.

Author information

1
Cardiology Section and Research Service, San Francisco VA Medical Center (111-C-8), 4150 Clement St., San Francisco, CA 94121, USA.

Abstract

Commercial antibodies are used widely to quantify and localize the alpha1-adrenergic receptor (AR) subtypes, alpha1A, alpha1B, and alpha1D. We tested ten antibodies, from abcam and Santa Cruz, using western blot with heart and brain tissue from wild-type (WT) mice and mice with systemic knockout (KO) of one or all three subtypes. We found that none of the antibodies detected a band in WT that was absent in the appropriate KO or in the KO that was null for all alpha1-ARs (ABDKO). We conclude that the antibodies we tested are not specific for alpha1-ARs. These results raise caution with prior studies using these reagents. For now, competition radioligand binding is the only reliable approach to quantify the alpha1-AR subtype proteins. Receptor protein localization remains a challenge.

PMID:
18989658
PMCID:
PMC2653258
DOI:
10.1007/s00210-008-0368-6
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Support Center